Table 2 Co-morbidities AD participants compared to controls
AD participants n = 187 | Controls n = 200 | Unadjusted p-value | Adjusted p-value* | |
|---|---|---|---|---|
Co-morbidity score | ||||
2.1 ± 1.5 | 1.3 ± 1.2 | < 0.001 | < 0.001 | |
Cardiovascular diseases** | ||||
n (%) | 139 (74) | 114 (57) | < 0.001 | 0.14 |
Angina pectoris | ||||
n (%) | 48 (26) | 18 (9) | < 0.001 | 0.37 |
Myocardial infarct | ||||
n (%) | 27 (14) | 24 (12) | 0.52 | 0.26 |
Atrial fibrillation | ||||
n (%) | 34 (18) | 18 (9) | 0.008 | 0.40 |
Stroke | ||||
n (%) | 33 (18) | 11 (6) | < 0.001 | 0.82 |
Hypertension | ||||
n (%) | 102 (55) | 82 (41) | 0.008 | 0.14 |
Diabetes mellitus | ||||
n (%) | 21 (11) | 17 (9) | 0.37 | 0.15 |
Chronic obstructive bronchitis | ||||
n (%) | 19 (10) | 10 (5) | 0.054 | 0.003 |
Chronic pain | ||||
n (%) | 47 (25) | 41 (21) | 0.28 | 0.17 |